ID   GLL-19
AC   CVCL_W181
SY   Gll-19; GLL19
DR   Wikidata; Q54835934
RX   PubMed=2174414;
RX   PubMed=2467885;
RX   PubMed=6746112;
CC   From: Blanquet, S. and Safi, Nour; Hopital Saint Andre; Bordeaux; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C8562; Ocular melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 7
//
RX   PubMed=2174414; DOI=10.1002/ijc.2910460629;
RA   Deschodt-Lanckman M.M., Vanneste Y., Loir B., Michel A., Libert A.,
RA   Ghanem G., Lejeune F.;
RT   "Degradation of alpha-melanocyte stimulating hormone (alpha-MSH) by
RT   CALLA/endopeptidase 24.11 expressed by human melanoma cells in
RT   culture.";
RL   Int. J. Cancer 46:1124-1130(1990).
//
RX   PubMed=2467885; DOI=10.1002/ijc.2910430421;
RA   Gross N., Beck D., Portoukalian J., Favre S., Carrel S.;
RT   "New anti-GD2 monoclonal antibodies produced from
RT   gamma-interferon-treated neuroblastoma cells.";
RL   Int. J. Cancer 43:665-671(1989).
//
RX   PubMed=6746112; DOI=10.1002/ijc.2910340104;
RA   Cillo C., Mach J.-P., Schreyer M., Carrel S.;
RT   "Antigenic heterogeneity of clones and subclones from human melanoma
RT   cell lines demonstrated by a panel of monoclonal antibodies and flow
RT   microfluorometry analysis.";
RL   Int. J. Cancer 34:11-20(1984).
//